Study Advocates for Treatment of Valve Disease in Heart Failure Patients

A recent study published in the British Medical Journal examined mitral regurgitation in patients with heart failure and found that mitral regurgitation was often viewed as part of the progression of heart failure and was not treated as a separate condition. Mitral regurgitation is associated with higher mortality rates, becomes more common with age, and is common in heart failure patients. However, valve disease in heart failure patients is rarely treated since these patients are often older and have comorbidities that make surgery riskier. Now there are new, less invasive catheter-based interventions, such as Mitraclip, that are safer alternatives to open heart surgery. This study has practical and political implications. It suggests that steps should be taken to screen and monitor for valve disease in heart failure patients, and if valve disease is diagnosed, new therapies for these high-risk patients should be considered.

Read the journal article here. Read a summary news release from EurekAlert here.

Bartko, P.E., et al. (2021) Burden, treatment use, and outcome of secondary mitral regurgitation across the spectrum of heart failure: observational cohort study. BMJ.